摘要
Recently, 2007, the U.S. Food and Drug Administration （FDA） issued a draft guidance for the industry, titled ＂Complementary and Alternative Medicine Products and Their Regulation by the Food and Drug Administration＂. This is another document closely related to Chinese Medical Sciences following the issuance of the Guidance for Industry： Botanical Drug Products in June 2004. This document conforms to the dramatically increased practice of Complementary and Alternative Medicine （CAM） in the United States in recent years.
Recently, 2007, the U.S. Food and Drug Administration （FDA） issued a draft guidance for the industry, titled ＂Complementary and Alternative Medicine Products and Their Regulation by the Food and Drug Administration＂. This is another document closely related to Chinese Medical Sciences following the issuance of the Guidance for Industry： Botanical Drug Products in June 2004. This document conforms to the dramatically increased practice of Complementary and Alternative Medicine （CAM） in the United States in recent years.
